BioNeutra Global

BioNeutra Global EBITDA per Share

The EBITDA per Share of BioNeutra Global (BGA.V) as of Oct 27, 2026 is -0.03 CAD. In the previous year, EBITDA per Share was -0.05 CAD — a change of -46.54% (higher).

EBITDA per Share

-0.03CAD

YoY

-46.54%

Last updated:

EBITDA per Share of BioNeutra Global is 2023 -0.03 CAD. EBITDA per Share of BioNeutra Global was 2022 -0.05 CAD. It decreases by -46.54% higher compared to the previous year.

The BioNeutra Global EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2016
0.08 CAD
Jan 1, 2017
0.02 CAD
Jan 1, 2018
0.07 CAD
Jan 1, 2019
-0.19 CAD
Jan 1, 2020
-0.05 CAD
Jan 1, 2021
-0.04 CAD
Jan 1, 2022
-0.05 CAD
Jan 1, 2023
-0.03 CAD
The BioNeutra Global EBITDA per Share history
YEAREBITDA per ShareYoY
-0.03CAD-46.54%
-0.05CAD+11.03%
-0.04CAD-16.02%
-0.05CAD-72.97%
-0.19CAD-363.26%
0.07CAD+205.31%
0.02CAD-71.25%
0.08CAD+120.03%
0.04CAD-51.91%
0.08CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioNeutra Global Stock analysis

What does BioNeutra Global do? BioNeutra Global Corp generates revenue through the research, development, production, and commercialization of nutraceutical, functional, and mainstream food and beverage ingredients. Its lead product, VitaFiber IMO, is a natural, low-calorie, soluble prebiotic fiber derived from agricultural crops like tapioca, field pea, or corn. The company sells VitaFiber IMO to small and medium enterprises and food manufacturers for incorporation into their products. Additionally, VitaFiber IMO is available for retail purchase via Amazon.com and Shopify.com, allowing direct consumer sales. VitaFiber IMO is produced using patented processes that transform starch molecules into isomalto-oligosaccharide (IMO), offering a naturally sweet alternative to sugar with digestive health benefits. The product targets health-conscious consumers seeking low-calorie, functional food ingredients, appealing to both manufacturers and end-users through its retail presence on global e-commerce platforms. BioNeutra's commercial model combines B2B sales to food manufacturers with direct-to-consumer retail on Amazon.com and Shopify.com, leveraging its patented technology to create a dual revenue stream. The company focuses on natural, health-oriented ingredients that align with growing market demands for functional foods and beverages. BioNeutra Global is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNeutra Global stock

EBITDA per Share of BioNeutra Global is -0.03 CAD in 2023.

EBITDA per Share of BioNeutra Global changed from -0.05 CAD to -0.03 CAD, representing a -46.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share BioNeutra Global since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — BioNeutra Global

All Key Metrics — BioNeutra Global